These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 21033014)
21. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Shekerdemian LS; Ravn HB; Penny DJ Am J Respir Crit Care Med; 2002 Apr; 165(8):1098-102. PubMed ID: 11956051 [TBL] [Abstract][Full Text] [Related]
22. Controversies in the use of inhaled nitric oxide therapy in the newborn. Kinsella JP; Abman SH Clin Perinatol; 1998 Mar; 25(1):203-17. PubMed ID: 9523083 [TBL] [Abstract][Full Text] [Related]
23. Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. Christou H; Van Marter LJ; Wessel DL; Allred EN; Kane JW; Thompson JE; Stark AR; Kourembanas S Crit Care Med; 2000 Nov; 28(11):3722-7. PubMed ID: 11098980 [TBL] [Abstract][Full Text] [Related]
25. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. Kinsella JP; Abman SH J Pediatr; 1995 Jun; 126(6):853-64. PubMed ID: 7776084 [TBL] [Abstract][Full Text] [Related]
26. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. Kinsella JP; Neish SR; Ivy DD; Shaffer E; Abman SH J Pediatr; 1993 Jul; 123(1):103-8. PubMed ID: 8320602 [TBL] [Abstract][Full Text] [Related]
35. [Research advances in persistent pulmonary hypertension of the newborn secondary to congenital diaphragmatic hernia]. Xiao B; Liu M; Xu C Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):1013-9. PubMed ID: 26412189 [TBL] [Abstract][Full Text] [Related]
36. Persistent pulmonary hypertension in the newborn: therapeutic effect of sildenafil. Cruz-Blanquel A; Espinosa-Oropeza A; Romo-Hernández G; Carrillo-Alarcón L; Ponce-Monter H; Ortiz MI Proc West Pharmacol Soc; 2008; 51():73-7. PubMed ID: 19544683 [TBL] [Abstract][Full Text] [Related]
37. Factors affecting the response to inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn infants. Hwang SJ; Lee KH; Hwang JH; Choi CW; Shim JW; Chang YS; Park WS Yonsei Med J; 2004 Feb; 45(1):49-55. PubMed ID: 15004868 [TBL] [Abstract][Full Text] [Related]
38. Current and future therapeutic options for persistent pulmonary hypertension in the newborn. Rao S; Bartle D; Patole S Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):845-62. PubMed ID: 20528642 [TBL] [Abstract][Full Text] [Related]
39. The use of sildenafil in the treatment of persistent pulmonary hypertension of the newborn: a review of the literature. Iacovidou N; Syggelou A; Fanos V; Xanthos T Curr Pharm Des; 2012; 18(21):3034-45. PubMed ID: 22564297 [TBL] [Abstract][Full Text] [Related]
40. Criteria for extracorporeal membrane oxygenation in a population of infants with persistent pulmonary hypertension of the newborn. Beck R; Anderson KD; Pearson GD; Cronin J; Miller MK; Short BL J Pediatr Surg; 1986 Apr; 21(4):297-302. PubMed ID: 3084751 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]